drugset / Trial / NCT01455649
Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate the efficacy and safety in the use of everolimus, with its onset after 3 months of treatment with calcineurin inhibitor.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclosporine | Peptide | — | — |
| Subject | Everolimus | Small molecule | 1 mg | — |
| Comparator | Tacrolimus | Small molecule | — | — |
Indications
No indication recorded.